Location: Home
  • search
  • go
  • Relate News
  • 8/12/2019Digital Must Deliver Both Speed and Depth
  • 8/11/2019Sale of U.S. Taxpayer-Funded New Antibiotic to Qilu Pharma Questioned
  • 8/11/2019Recent Executive Moves
  • 8/8/2019Chinese Government Forms National Level Advisory Committee for Researc...
  • 8/7/2019Mitsubishi Tanabe ALS Drug Edaravone Approved in China
  • 8/6/2019NHSA Begins Preparation for Expanded 4+7 Trial
  • 8/5/2019Central Government to Reform Electronic Bills/Invoices/Receipts for Me...
  • 8/5/2019CPhC Publicizes Technical Guidelines for Premix and Co-treatment of Ph...
  • 8/2/2019I-Mab and TRACON Initiate Phase 1 Trial of CD73 Antibody TJD5
  • 8/2/2019Chinese Drug Developer I-Mab Biopharma Files for U.S. IPO
  • 8/2/2019Dealing with the Chinese Challenge: The Case of the Pharma Industry
  • 8/2/2019NMPA Information Center Launches Drug MAH Database
  • 8/1/2019ASEAN and China Biosimilars Market Poised for CAGR Growth at 29.7% Bef...
  • 8/1/2019MediBeacon Enters into $30 Million Investment and Exclusive Commercial...
  • 8/1/2019China Approved 139 New Drugs Supported by the National S&T Major P...
  • 8/1/2019NHSA: Initial Draft for Implementation Rules of Internet Healthcare Pr...
  • 7/31/2019China's Big Data Draws Big Pharma
  • 7/31/2019Financial-related Company News in Brief
  • 7/30/2019Xynomic Received China Approval to Start 2 Pivotal Lymphoma Clinical T...
  • 7/30/2019Chi-Med Set to Add Two New Anticancer Registration Filings in China
  • 7/30/2019CCDCP: China to Take Effective Measures to Curb Senile Dementia
  • 7/29/2019Pfizer to Absorb Mylan, Creating Global Generic Powerhouse
  • 7/29/2019Amarillo Bio and Xiamen Weiyang Pharma Sign Term Sheet for China Licen...
  • 7/29/2019Pfizer Gets Accelerated Review and Foreign Clinical Data Acceptance in...
  • 7/26/2019Recent Executive Moves
  • 7/26/2019Investing in China's Healthtech Industry
  • 7/26/2019China Drug-Buying Overhaul Triggers a Flood of Profit Warnings
  • 7/25/2019NHSA Reports the Implementation Progress of Ongoing 4+7 Trial
  • 7/25/2019AstraZeneca Raises 2019 Sales Forecast on Strong Q2 China Performance ...
  • 7/24/2019Outsourcing in China: How Far Can It Go?
  • Page:135/357 Total number of articles:10695: [First][<<] [133] [134] [135] [136] [137] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group